Wells Fargo upgraded AptarGroup (ATR) to Overweight from Equal Weight with a price target of $144, up from $133. The firm says the share price reaction relating to the Iran conflict has been “disproportionate” across the packaging sector. Wells prefers companies with low leverage, high U.S concentration, and “defensive” production exposures. The analyst adjusted ratings in the group. AptarGroup offers a “best-in-class” balance sheet and heavy exposure to the “defensive” pharma sector, which is key during periods of uncertainty, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATR:
- AptarGroup’s unidose powder nasal delivery system used in ENA Phase 2 study
- AptarGroup Announces CEO Succession and Leadership Transition Plan
- AptarGroup CEO Stephan Tanda to retire, Gael Touya to succeed
- AptarGroup: Solid Strategic Position and Structural Growth Offset by Near-Term Earnings Headwinds, Warranting a Hold Rating
- AptarGroup Earnings Call Balances Growth With Margin Strain
